Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

Pasquale Paolisso(CTO Andrea Alesini), Emanuele Barbato(CTO Andrea Alesini), Gaetano Santulli(Albert Einstein College of Medicine), Arturo Cesaro(University of Campania "Luigi Vanvitelli"), Felice Gragnano(Ospedale Sant'Anna), Dobrin Vassilev, Carmine Pizzi(Azienda USL di Bologna), Alberto Foà(Azienda USL di Bologna), Giuseppe Esposito(Sapienza University of Rome), Raffaele Marfella(University of Campania "Luigi Vanvitelli"), Luca Bergamaschi(Ospedale G.B. Morgagni - L.Pierantoni), Ciro Mauro, Sara Amicone(University of Bologna), Angelo Sansonetti(University of Bologna), Oreglia Jacopo Andrea(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Nazzareno Galiè(Azienda USL di Bologna), Gianni Casella, Andrea Impellizzeri(I.R.C.C.S. Oasi Maria SS), Niya Mileva(Medical University of Sofia), Matteo Armillotta(University of Bologna), Nuccia Morici(Don Carlo Gnocchi Foundation), Paolo Calabrò(University of Campania "Luigi Vanvitelli"), Celestino Sardu(University of Campania "Luigi Vanvitelli"), Emanuele Gallinoro(Al-Azhar University)
Pharmacological Research
December 5, 2022
Cited by 146


Related Papers